Table 8.

Difference in means between treatment and control groups for HDL at final follow-up

Author	Sample size (treatment group vs. control group)	Difference	95% CI
Cabral et al. [57]	32 (14 vs. 18)	0.26 mmol/L*	− 0.17 to 0.70
Caraccio et al. [58]	49 (24 vs. 25)	− 0.10 mmol/L*	− 0.27 to 0.07
Duman et al. [60]	39 (20 vs. 19)	0.004 mmol/L*	− 0.45 to 0.44
Iqbal et al. [62]	64 (32 vs. 32)	0.00 mmol/L*	− 0.22 to 0.22
Liu et al. [64]	119 (60 vs. 59)	0.03 mmol/L**	− 0.03 to 0.09
Mikhail et al. [66]	120 (60 vs. 60)	0.09 mmol/L*	− 0.01 to 0.20
Monzani et al. [68]	45 (23 vs. 22)	− 0.17 mmol/L*	− 0.49 to 0.14
Nagasaki et al. [69]	95 (48 vs. 47)	0.02 mmol/L**	− 0.12 to 0.16
Teixeira et al. [74, 75]	26 (11 vs. 15)	0.35 mmol/L*	− 0.29 to 0.99

*Value is the difference in mean scores at final follow-up between treatment and control groups

**Value is the difference in mean variation scores from baseline to follow-up between treatment and control group